Cambridge, United Kingdom
Fluidic Analytics, a pioneering entity in the Biotechnology and Life Sciences sectors, is reshaping how protein interactions are quantified for various applications, including diagnostics and precision medicine. Established in 2013 and headquartered in the United Kingdom, the company has carved out a unique niche by developing advanced tools to characterize proteins with greater accuracy.
Their slogan, "A fundamentally new way of quantifying protein interactions for diagnostics, drug discovery and precision medicine," encapsulates their mission to enhance our grasp of protein behavior, thereby aiding in the betterment of disease diagnostics and treatment development. Fluidic Analytics' instruments and software aim to democratize access to these essential technologies across labs, clinics, and homes, breaking barriers for a broader demographic.
In a strategic move, the company secured a $31.00M Series C investment on 26 November 2018, with backing from key investors including Amadeus Capital Partners, Molten Ventures, IQ Capital, Delin Ventures, and BGF Industries.
